Private Prescription Access: Skip the NHS Queue Today
What Is Better Wegovy or Mounjaro: The Private Prescription Advantage
When considering what is better Wegovy or Mounjaro, the private prescription route offers significant advantages over NHS pathways. The NHS typically requires GP referral to specialist weight management services, with waiting times often exceeding 6 months before treatment begins. Private prescriptions through EverydayMeds eliminate this delay entirely, allowing eligible patients to access either medication within days of their initial assessment.
The choice between these medications becomes less about availability and more about clinical suitability when accessed privately. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors. Both are prescription-only medicines that require clinical assessment, but private prescribers can evaluate your individual circumstances without the restrictive criteria often applied in NHS settings.
Wegovy vs Mounjaro Pricing: Complete Private Prescription Costs
Understanding what is better Wegovy or Mounjaro often comes down to practical considerations like cost and dosing schedules. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (after applying code FIRST40), progressing through £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenient multi-month supplies, such as the Intro Trio covering months 1-3 for £299.99.
Both medications follow structured dose escalation protocols, but Wegovy's 5-dose progression differs from Mounjaro's approach. The Getting Started Bundles ensure seamless transitions between doses - the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is available for £189.99. Returning customers benefit from code DOSE25 applied at checkout, with all prices including cold-chain delivery and prescriber review fees.
Clinical Evidence: What Is Better Wegovy or Mounjaro Based on Trials
When evaluating what is better Wegovy or Mounjaro through clinical evidence, both medications have demonstrated significant efficacy in their respective trial programmes. The STEP trials showed that patients taking Wegovy alongside diet and exercise achieved average weight reductions of approximately 15% at 68 weeks, with the SELECT cardiovascular outcomes trial revealing a 20% reduction in major cardiovascular events. These results represent controlled clinical conditions and individual responses may vary considerably.
Mounjaro's SURMOUNT trials demonstrated its dual-agonist mechanism targeting both GLP-1 and GIP receptors, though direct head-to-head comparisons between the medications remain limited due to different trial designs and populations. Both medications are subject to MHRA additional monitoring and must be prescribed alongside a reduced-calorie diet and increased physical activity as part of comprehensive weight management programmes.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of naturally occurring incretin hormones that regulate blood glucose and appetite. The medication binds to GLP-1 receptors in the brain's appetite control centres, particularly the hypothalamus, where it may help reduce food cravings and promote earlier satiety signals. This mechanism can lead to smaller portion sizes feeling more satisfying, supporting the caloric deficit necessary for weight management. Unlike rapid-acting appetite suppressants, Wegovy's effects build gradually through the dose escalation period, allowing the body to adapt to reduced caloric intake. The once-weekly injection schedule using the FlexTouch pen device provides consistent medication levels, avoiding the daily dosing fluctuations seen with some other weight management approaches.
Private Prescription Ordering Process: 3 Minutes to Treatment Access
The streamlined private prescription process begins with a comprehensive 3-minute clinical assessment covering medical history, current medications, and weight management goals. This assessment is reviewed by our registered prescribers within 3 working days (or 24 hours with express service), who determine eligibility based on MHRA-licensed indications for adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. Once approved, medications are dispatched via next-day cold-chain delivery to maintain the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) ensures all medications are genuine manufacturer stock, with full traceability and patient support throughout treatment. The entire process eliminates GP appointments, specialist referrals, and extended waiting periods associated with traditional NHS pathways.
Storage and Practical Considerations: Wegovy vs Mounjaro Lifestyle Factors
When considering what is better Wegovy or Mounjaro for your lifestyle, storage requirements present a key differentiator. Wegovy can be stored at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage makes Wegovy more suitable for frequent travellers, business professionals, or anyone whose routine doesn't assurance consistent refrigerator access. Both medications require initial refrigerated storage at 2-8°C before first use, and the FlexTouch pen design provides user-friendly injection mechanisms. The dose escalation schedule for Wegovy spans 16 weeks to reach maintenance dose, allowing gradual adaptation to the medication's effects whilst minimising potential gastrointestinal side effects that can occur with rapid dose increases.
What Is Better Wegovy or Mounjaro: Individual Response Factors
Determining what is better Wegovy or Mounjaro ultimately depends on individual patient factors including medical history, lifestyle requirements, and previous treatment responses. Patients with certain gastrointestinal conditions may respond differently to single-agonist versus dual-agonist mechanisms, whilst those with demanding travel schedules might benefit from Wegovy's extended room temperature stability. Some individuals may find the different injection schedules or pen designs more suitable for their personal preferences and dexterity requirements.
Both medications are available through EverydayMeds' private prescription service, allowing our prescribers to evaluate your specific circumstances without the standardised protocols often required in NHS settings. This personalised approach considers factors like concurrent medications, medical history, and lifestyle demands that can influence treatment success. Rather than being constrained by waiting lists or limited formulary options, private prescription access enables more nuanced treatment decisions based purely on clinical appropriateness.
Secure Your Private Prescription: Next-Day Access to Weight Management
Both Wegovy and Mounjaro represent significant advances in prescription weight management, each offering distinct advantages depending on your individual circumstances. Private prescription access through EverydayMeds eliminates the barriers that prevent many people from starting treatment, including lengthy NHS queues and restrictive referral criteria. New customers can begin their assessment today using code FIRST40, whilst returning patients benefit from code DOSE25 applied at checkout. Our cold-chain delivery ensures medication integrity from our GPhC-registered pharmacy (#9012878) directly to your door, with comprehensive patient support throughout your treatment journey. The choice between these medications should be based on clinical factors rather than availability - both are accessible within days through our streamlined private prescription service.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
